At a glance
- Originator Apollo BioPharmaceutics
- Developer Apollo BioPharmaceutics; Endocon
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 22 Dec 1999 Discontinued-Preclinical for Alzheimer's disease in USA (SC)
- 07 Nov 1997 Preclinical development for Alzheimer's disease in USA (SC)